EMBC Embecta Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: EMBC

Price (delayed)

$5.565

Market cap

$315.31M

P/E Ratio

3.71

Dividend/share

$0.32

EPS

$1.5

Enterprise value

$1.58B

?
Relative Growth: Rel. Growth: 22
Relative Strength: Rel. Strength: 49
Relative Valuation: Rel. Valuation: 95
Relative Profitability: Rel. Profitability: 50
Highlights
The price to earnings (P/E) is 66% less than the 5-year quarterly average of 11.0 and 27% less than the last 4 quarters average of 5.1
Embecta's equity has increased by 8% YoY and by 2.1% QoQ
EMBC's net income is down by 22% since the previous quarter but it is up by 4.7% year-on-year
EMBC's EPS is down by 22% since the previous quarter but it is up by 4.9% year-on-year
The quick ratio has declined by 37% year-on-year and by 31% since the previous quarter
EMBC's gross profit is down by 13% YoY and by 7% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://www.embecta.com
Peers: OFIX

Key stats

What are the main financial stats of EMBC

EMBC stock price

How has the Embecta stock price performed over time
Intraday
-0.27%
1 week
7.23%
1 month
11.52%
1 year
-61.88%
YTD
-53.16%
QTD
70.71%

Financial performance

How have Embecta's revenue and profit performed over time
Revenue
$1.02B
Gross profit
$601.3M
Operating income
$223.5M
Net income
$87.5M
Gross margin
59%
Net margin
8.6%
EMBC's net income is down by 22% since the previous quarter but it is up by 4.7% year-on-year
The net margin fell by 20% QoQ but it rose by 13% YoY
The operating income has declined by 17% since the previous quarter but it is up by 6% year-on-year
The operating margin has decreased by 15% from the previous quarter but it has increased by 14% YoY

Price vs fundamentals

How does EMBC's price correlate with its fundamentals

Growth

What is Embecta's growth rate over time

Valuation

What is Embecta stock price valuation
EMBC P/E details
P/E
3.71
P/B
N/A
P/S
0.32
EV/EBIT
7.14
EV/EBITDA
5.8
EV/Sales
1.55
The price to earnings (P/E) is 66% less than the 5-year quarterly average of 11.0 and 27% less than the last 4 quarters average of 5.1
EMBC's EPS is down by 22% since the previous quarter but it is up by 4.9% year-on-year
Embecta's equity has increased by 8% YoY and by 2.1% QoQ
The stock's price to sales (P/S) is 64% less than its 5-year quarterly average of 0.9 and 36% less than its last 4 quarters average of 0.5
Embecta's revenue has decreased by 8% YoY and by 2.3% from the previous quarter

Efficiency

How efficient is Embecta business performance
The ROA has contracted by 23% from the previous quarter but it has grown by 11% YoY
The return on invested capital has declined by 17% since the previous quarter but it is up by 14% year-on-year
EMBC's return on sales is down by 16% since the previous quarter but it is up by 14% year-on-year

Dividends

What is EMBC's dividend history
Dividend details
DPS
$0.32
Dividend yield
5.75%
Payout ratio
21.3%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Embecta financials performed over time
The total assets is 33% less than the total liabilities
The quick ratio has declined by 37% year-on-year and by 31% since the previous quarter
Embecta's current ratio has decreased by 32% YoY and by 32% QoQ
The debt to equity has contracted by 12% from the previous quarter and by 8% YoY
The debt rose by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.